Stork, C.L., Matloub, Y., Broxson, E., et al. (2010) Oral 6-mercaptopurine versus oral 6-thioguanine and Veno-Occlusive Disease in Children with Standard-Risk Acute Lymphoblastic Leukemia: Report of the Children’s Oncology Group CCG-1952 Clinical Trial. Blood, 115, 2740-2748.
https://doi.org/10.1182/blood-2009-07-230656

has been cited by the following article:

• TITLE: Severe Hepatic Sinusoidal Obstruction Syndrome during the Induction Chemotherapy of Burkitt’s Lymphoma

  AUTHORS: Line Couitchere, Yao Nicaise Atiméré, Daouda Koné, Delphine Lagou

  KEYWORDS: Lymphoma, Treatment, Veno-Occlusive Disease, Multi Organ Failure

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.8 No.1, March 9, 2018

  ABSTRACT: The Hepatic sinusoidal obstruction syndrome (HSOS), also known as veno-occlusive disease (VOD), is a well-known complication of haematopoietic stem cell transplantation, of the treatment of Wilms tumor and rhabdomyosarcoma and maintenance therapy of acute lymphoblastic leukemias. Its occurrence is rare in other cancers of the child. We report the observation of a 7-year-old girl with Burkitt’s lymphoma who developed a severe HSOS during her second induction treatment with dexamethasone, cisplatin, cytosine arabinoside. The evolution was fatal. This observation shows that the diagnosis of HSOS should not be excluded in the absence of the risk factors usually described.